Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial
- PMID: 2175265
- DOI: 10.1007/BF02190083
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial
Abstract
A double-blind study was performed comparing 5 mg delta-9-tetrahydrocannabinol (THC) p.o., 50 mg codeine p.o., and placebo in a patient with spasticity and pain due to spinal cord injury. The three conditions were applied 18 times each in a randomized and balanced order. Delta-9-THC and codeine both had an analgesic effect in comparison with placebo. Only delta-9-THC showed a significant beneficial effect on spasticity. In the dosage of THC used no altered consciousness occurred.
Similar articles
-
Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.Pain. 2003 Nov;106(1-2):169-72. doi: 10.1016/s0304-3959(03)00331-2. Pain. 2003. PMID: 14581124 Clinical Trial.
-
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.Health Technol Assess. 2015 Feb;19(12):vii-viii, xxv-xxxi, 1-187. doi: 10.3310/hta19120. Health Technol Assess. 2015. PMID: 25676540 Free PMC article. Clinical Trial.
-
Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.Ther Drug Monit. 2006 Aug;28(4):545-51. doi: 10.1097/00007691-200608000-00010. Ther Drug Monit. 2006. PMID: 16885723 Clinical Trial.
-
Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.Drugs R D. 2003;4(5):306-9. doi: 10.2165/00126839-200304050-00005. Drugs R D. 2003. PMID: 12952500 Review.
-
Multifocal intradural extramedullary ependymoma. Case report.J Neurosurg Spine. 2011 Jan;14(1):65-70. doi: 10.3171/2010.9.SPINE09963. Epub 2010 Dec 10. J Neurosurg Spine. 2011. PMID: 21142461 Review.
Cited by
-
Absorbance-Transmittance Excitation Emission Matrix Method for Quantification of Major Cannabinoids and Corresponding Acids: A Rapid Alternative to Chromatography for Rapid Chemotype Discrimination of Cannabis sativa Varieties.Cannabis Cannabinoid Res. 2023 Oct;8(5):911-922. doi: 10.1089/can.2021.0165. Epub 2022 Apr 29. Cannabis Cannabinoid Res. 2023. PMID: 35486823 Free PMC article.
-
Cannabinoid-based medicines for neurological disorders--clinical evidence.Mol Neurobiol. 2007 Aug;36(1):129-36. doi: 10.1007/s12035-007-0003-4. Epub 2007 Jun 29. Mol Neurobiol. 2007. PMID: 17952657 Review.
-
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Curr Neuropharmacol. 2006 Jul;4(3):239-57. doi: 10.2174/157015906778019527. Curr Neuropharmacol. 2006. PMID: 18615144 Free PMC article.
-
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.Neurotherapeutics. 2009 Oct;6(4):713-37. doi: 10.1016/j.nurt.2009.08.002. Neurotherapeutics. 2009. PMID: 19789075 Free PMC article. Review.
-
Pharmacokinetics and pharmacodynamics of cannabinoids.Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical